Folate transporter expression in placenta from pregnancies complicated with birth defects.

Area of Science:

• Obstetrics and Gynecology
• Developmental Biology
• Nutritional Science

Background:

• Folate is essential for fetal development, supporting cell division, embryogenesis, and growth.
• Maternal folate supply is critical for fetal well-being, transported across the placenta.
• Dysregulation of folate transport may contribute to adverse pregnancy outcomes.

Purpose of the Study:

• To compare the placental expression of key folate transporters: Folate Receptor-α (FR-α), Reduced Folate Carrier (RFC), and Proton Coupled Folate Transporter (PCFT).
• To investigate potential differences in transporter expression between pregnancies complicated by birth defects (BD) and controls.

Main Methods:

• A case-control study design was employed, analyzing placental tissues from 25 pregnancies with BD and 25 controls.
• Immunohistochemistry was utilized to determine the placental expression levels of FR-α, RFC, and PCFT.
• Optical density measurements provided relative quantification of protein expression.

Main Results:

• Placental expression of PCFT was significantly higher in pregnancies with BD compared to controls (p < .01).
• No significant differences in the placental expression of FR-α or RFC were observed between the BD and control groups.

Conclusions:

• Increased PCFT expression in placentas from BD-complicated pregnancies suggests a potential adaptive mechanism.
• This upregulation may aim to enhance folate transport across the maternal-fetal interface.
• Further research is warranted to elucidate the precise role of PCFT in the pathophysiology of birth defects.